New predictive window to Kidney Health

The Serenno system is a pioneering Urine Output (UO) Monitor
for hospitalized patients improving
Acute Kidney Injury (AKI) prediction
and fluid management.

The problem

Acute Kidney Injury (AKI) - an avoidable, dangerous and common complication that affects 19 million patients worldwide every year.
AKI is hard to treat and reverse once it manifests fully.

About AKI and Fluid Overload

The Solution

Continuous UO measurement - the only reliable way to detect, assess, possibly anticipate AKI occurrence.
Earlier AKI detection – reduces patient risk and renders most cases preventable.

The Serenno system advantages:

Fully automatic, low workload, hands free

EMR Connected, delivering more actionable data

Safe, robust and reliable for every patient

Low cost, easy to use, streamline into the ICU

Unique use options

ER>OR>ICU mobility

Quarantine
ICU

Telehealth/
Remote ICU

Home
ICU

Kidney failure is among the most common and dangerous ICU complications. Typically, kidney injury is detected relatively late, often after it is impossible to prevent further progression... The Serenno system will promote early detection of kidney injury, presumably while there is still time to intervene and prevent further damage.

Daniel I. Sessler, MD

Cleveland Clinic, Serenno Medical Advisor

Team

The Serenno team combines over 70 years of experience in all aspects of the medical device business.

Tomer Lark

CEO, Founder

Noam Hadas

CTO, Founder

Sagie Meshulam

VP R&D

Anna Levin

VP Clinical/Regulatory

Join the team